Chemometec A/S
CSE:CHEMM

Watchlist Manager

Chemometec A/S

CSE:CHEMM

Watchlist

Dividends

Discount Rate

Price: 493.4 DKK -1.52% Market Closed

Market Cap: 8.6B DKK

Have any thoughts about
Chemometec A/S?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 493.4 DKK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

CHEMM Alert

Chemometec A/S

493.4

-7.6 (-1.52%)

52 Week Range	282.4 553.5
Price Target

We'll email you a reminder when the closing price reaches DKK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Chemometec A/S

What unique competitive advantages
does Chemometec A/S hold over its rivals?

What risks and challenges
does Chemometec A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Chemometec A/S.

What unique competitive advantages
does Chemometec A/S hold over its rivals?

What risks and challenges
does Chemometec A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Chemometec A/S.

Provide P/S
for Chemometec A/S.

Provide P/E
for Chemometec A/S.

Provide P/OCF
for Chemometec A/S.

Provide P/FCFE
for Chemometec A/S.

Provide P/B
for Chemometec A/S.

Provide EV/S
for Chemometec A/S.

Provide EV/GP
for Chemometec A/S.

Provide EV/EBITDA
for Chemometec A/S.

Provide EV/EBIT
for Chemometec A/S.

Provide EV/OCF
for Chemometec A/S.

Provide EV/FCFF
for Chemometec A/S.

Provide EV/IC
for Chemometec A/S.

Show me price targets
for Chemometec A/S made by professional analysts.

What are the Revenue projections
for Chemometec A/S?

How accurate were the past Revenue estimates
for Chemometec A/S?

What are the Net Income projections
for Chemometec A/S?

How accurate were the past Net Income estimates
for Chemometec A/S?

What are the EPS projections
for Chemometec A/S?

How accurate were the past EPS estimates
for Chemometec A/S?

What are the EBIT projections
for Chemometec A/S?

How accurate were the past EBIT estimates
for Chemometec A/S?

Compare the revenue forecasts
for Chemometec A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Chemometec A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Chemometec A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Chemometec A/S compared to its peers.

Compare the P/E ratios
of Chemometec A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Chemometec A/S with its peers.

Analyze the financial leverage
of Chemometec A/S compared to its main competitors.

Show all profitability ratios
for Chemometec A/S.

Provide ROE
for Chemometec A/S.

Provide ROA
for Chemometec A/S.

Provide ROIC
for Chemometec A/S.

Provide ROCE
for Chemometec A/S.

Provide Gross Margin
for Chemometec A/S.

Provide Operating Margin
for Chemometec A/S.

Provide Net Margin
for Chemometec A/S.

Provide FCF Margin
for Chemometec A/S.

Show all solvency ratios
for Chemometec A/S.

Provide D/E Ratio
for Chemometec A/S.

Provide D/A Ratio
for Chemometec A/S.

Provide Interest Coverage Ratio
for Chemometec A/S.

Provide Altman Z-Score Ratio
for Chemometec A/S.

Provide Quick Ratio
for Chemometec A/S.

Provide Current Ratio
for Chemometec A/S.

Provide Cash Ratio
for Chemometec A/S.

What is the historical Revenue growth
over the last 5 years for Chemometec A/S?

What is the historical Net Income growth
over the last 5 years for Chemometec A/S?

What is the current Free Cash Flow
of Chemometec A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Chemometec A/S.

CHEMM

Income Statement

Revenue

Chemometec A/S
Revenue

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Chemometec A/S
Revenue Peer Comparison

Comparables:

GUBRA

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company		Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Chemometec A/S CSE:CHEMM	Revenue kr407.9m	CAGR 3-Years 13%	CAGR 5-Years 18%	CAGR 10-Years N/A
G	Gubra A/S CSE:GUBRA	Revenue kr205m	CAGR 3-Years 6%	CAGR 5-Years N/A	CAGR 10-Years N/A

What is Chemometec A/S's Revenue?

Revenue
407.9m DKK

Based on the financial report for Jun 30, 2024, Chemometec A/S's Revenue amounts to 407.9m DKK.

What is Chemometec A/S's Revenue growth rate?

Revenue CAGR 5Y
18%

Over the last year, the Revenue growth was -8%. The average annual Revenue growth rates for Chemometec A/S have been 13% over the past three years , 18% over the past five years .

Chemometec A/S
CSE:CHEMM

Chemometec A/S
Revenue

Chemometec A/S
Revenue Peer Comparison

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

See Also

What is Chemometec A/S's Revenue?

Revenue
407.9m DKK

What is Chemometec A/S's Revenue growth rate?

Revenue CAGR 5Y
18%

Company

Help

Tools

Stocks

Chemometec A/S CSE:CHEMM

Chemometec A/S Revenue

Chemometec A/S Revenue Peer Comparison

Competitive Revenue Analysis Latest Figures & CAGR of Competitors

See Also

What is Chemometec A/S's Revenue? Revenue 407.9m DKK

What is Chemometec A/S's Revenue growth rate? Revenue CAGR 5Y 18%

Company

Help

Tools

Stocks

Chemometec A/S
CSE:CHEMM

Chemometec A/S
Revenue

Chemometec A/S
Revenue Peer Comparison

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

What is Chemometec A/S's Revenue?

Revenue
407.9m DKK

What is Chemometec A/S's Revenue growth rate?

Revenue CAGR 5Y
18%